Navigation Links
ThirdBiotech Announces Kemeta as Newest Sponsor
Date:8/8/2008

PHOENIX, Aug. 8 /PRNewswire/ -- ThirdBiotech Inc., (http://www.thirdbiotech.com), a biotechnology incubator and life sciences association, today announced that Kemeta, a medical device company specializing in the development and manufacture of breath acetone sensing technology and products, has become ThirdBiotech's newest sponsor.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070911/LATU119LOGO)

"We've successfully established ThirdBiotech as an organization for bringing together the life sciences industry. Now with the establishment of ThirdBiotech Research Group Incubator and Molecular Engineering Research Institute (MERI), we have a core competency center to support and facilitate transformation of researchers and technology into biotech and biodevice companies," said Jeff Morhet, Founder of ThirdBiotech. "We are pleased to have Kemeta join our growing group of sponsors including Arizona Cure, BIO5/University of Arizona, Business Auxiliary Service Corp, Canadian Arizona Business Council, Galbut & Galbut, GE Healthcare, Greater Phoenix Economic Council, InNexus Biotechnology and Osborn Maledon."

The next ThirdBiotech event will be held at 6PM on Thursday, August 21st at La Bocca Pizzeria & Wine Bar located at 7th and Mill Avenue in downtown Tempe, Arizona.

About Kemeta

Kemeta has developed a unique, compact breath analyzer to provide individuals on a weight loss regimen rapid and accurate feedback regarding their fat metabolism using breath acetone as the body's biomarker. The company name, Kemeta, is derived from ketone and metabolism.

Kemeta is a privately held, limited liability company headquartered in Mesa, Arizona. Kemeta has a fully equipped, state-of-the-art R&D laboratory to develop, commercialize and expand Kemeta's products and technology. For more information about Kemeta, and their products and technology, visit them on the web at http://www.kemeta.com.

About ThirdBiotech

ThirdBiotech, created to foster networking and collaboration for the biotech, life sciences and healthcare community, provides research resources and drug development expertise for early technology companies while assembling a pathway for researchers to develop and fund themselves into biotechnology companies committed to creating products and value.

ThirdBiotech has been instrumental in building critical life sciences infrastructure along with establishing Arizona's Annual Biotech Day, produced numerous critical life sciences reports, supporting the founding of multiple university biotech clubs and hosting monthly events at trendy spots which feature no lectures, just fun and attended by a variety of industry professionals, including entrepreneurs, investors, attorneys, scientists and journalists.

For more information about ThirdBiotech and how the group is building a life science industry, visit us on the web at http://www.thirdbiotech.com.


'/>"/>
SOURCE ThirdBiotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies
2. ThirdBiotech Networking Group Launches
3. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
4. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
5. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Anesiva Announces Second Quarter 2008 Financial Results and Update
8. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
9. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
10. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
11. Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa Eradication Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Diego, CA (PRWEB) , ... June 27, 2016 , ... ... solutions for clinical trials, announced today the Clinical Reach Virtual Patient Encounter ... their care circle with the physician and clinical trial team. , Using the CONSULT ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):